Khiron Life Sciences
(OTC) KHRNF
Khiron Life Sciences Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$16.14M
Net Income (TTM)
$30.66M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
679.69 (High)
Dividend
$0.00
Beta (Volatility)
679.69 (High)
Price
$0.00
Volume
13,773
Open
$0.00
Price
$0.00
Volume
13,773
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Dividend
$0.00
Beta (Volatility)
679.69 (High)
Price
$0.00
Volume
13,773
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
KHRNF News
KHRNF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Khiron Life Sciences
Industry
Pharmaceuticals
Sector
Health CareEmployees
310
CEO
Álvaro F. Torres, MBA
Website
www.khiron.caHeadquarters
Vancouver, BC V6C 2B5, CA
KHRNF Financials
Key Financial Metrics (TTM)
Gross Margin
22%
Operating Margin
-2%
Net Income Margin
-3%
Return on Equity
0%
Return on Capital
-65%
Return on Assets
-78%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$0.00
Shares Outstanding
0
Volume
13.77K
Short Interest
0.00%
Avg. Volume
53.00K
Financials (TTM)
Gross Profit
$6.37M
Operating Income
$19.79M
EBITDA
$32.03M
Operating Cash Flow
$20.40M
Capital Expenditure
$1.74M
Free Cash Flow
$22.14M
Cash & ST Invst.
$8.92M
Total Debt
$2.23M
Khiron Life Sciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$3.38M
-3.8%
Gross Profit
$1.65M
-8.8%
Gross Margin
48.83%
N/A
Market Cap
$0.00
N/A
Market Cap/Employee
N/A
N/A
Employees
310
N/A
Net Income
$3.58M
-7.2%
EBITDA
$2.89M
+32.3%
Quarterly Fundamentals
Net Cash
$626.00K
-104.6%
Accounts Receivable
$4.38M
+7.3%
Inventory
$9.81M
-1.3%
Long Term Debt
$1.34M
N/A
Short Term Debt
$1.23M
+290.3%
Return on Assets
-78.37%
N/A
Return on Invested Capital
-64.62%
N/A
Free Cash Flow
$5.92M
-16.8%
Operating Cash Flow
$5.04M
-3.9%